Tus kws kho mob
P2-19 New Medical Drug-Related Prior Authorization Requirements for Revcovi, Gamifant, Lemtrada and Rituyan
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2019
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2841 - 2850 ntawm 3669
Tus kws kho mob
P7-19 eviCore CPT Code Updates for Fully Insured Commercial and Medicare Advantage Subscribers - eviCore Healthcare Specialty Utilization Management Program
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2019
Tus kws kho mob
QP71-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 21, 2018
Tus kws kho mob
QP90-18 Addition of Drugs to the Self-Administered Oncology Agents Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP69-18 Universal Pharmacy Policy for Minnesota Health Care Programs Subscribers - Morphine Equivalent Dose (MED) Limit Update
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 21, 2018
Tus kws kho mob
QP96-18 Clarification Regarding the use of PLUTO for Minnesota Health Care Program Subscribers Effective December 1, 2018
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP81-18 Changes to Cotiviti Mailroom Operations Center Location
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 25, 2018
Tus kws kho mob
QP78-18 Pharmacy Update - Change in Coverage for Brand Serevent Diskus 50 mcg/dose
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 11, 2018
Tus kws kho mob
QP106-18 Migration of Minnesota Health Care Programs Frequently Asked Questions (FAQ)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 12, 2018